Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021 - Seite 3

[1] Philips Mobile Interventional Applications Platform – IntraSight Mobile – is CE marked for sale in Europe and has received FDA 510(k) clearance for sale in the U.S.
[2] Philips Pressure Guide Wire – OmniWire – is CE marked for sale in Europe and has received FDA 510(k) clearance for sale in the U.S.
[3] Philips Laser System is CE marked for sale in Europe. The system is not currently available for sale in the U.S.
[4] ISR indicated for ELCA (P002208) and the Turbo-Power (P015612)

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel.: [phone]
E-mail: [e-mail]

Fabienne van der Feer
Philips Image Guided Therapy
Tel: + 31 622 698 001
E-mail : [e-mail]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• Philips Azurion PCI procedure
• Philips Laser System
• Philips OmniWire Pressure Guide Wire 3D view